Mechanisms of Impaired Fasting Glucose and Glucose Intolerance Induced by a ∼50% Pancreatectomy

Impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) often coexist and as such represent a potent risk factor for subsequent development of type 2 diabetes. β-Cell mass is ∼50% deficient in IFG and ∼65% deficient in type 2 diabetes. To establish the effect of a ∼50% deficit in β-cell mass on carbohydrate metabolism, we performed a ∼50% partial pancreatectomy versus sham surgery in 14 dogs. Insulin secretion was quantified from insulin concentrations measured in the portal vein at 1-min sampling intervals under basal conditions, after a 30-g oral glucose, and during a hyperglycemic clamp. Insulin sensitivity was measured by a hyperinsulinemic-euglycemic clamp combined with isotope dilution. Partial pancreatectomy resulted in IFG and IGT. After partial pancreatectomy both basal and glucose-stimulated insulin secretion were decreased through the mechanism of a selective ∼50 and ∼80% deficit in insulin pulse mass, respectively (P < 0.05). These defects in insulin secretion were partially offset by decreased hepatic insulin clearance (P < 0.05). Partial pancreatectomy also caused a ∼40% decrease in insulin-stimulated glucose disposal (P < 0.05), insulin sensitivity after partial pancreatectomy being related to insulin pulse amplitude (r = 0.9, P < 0.01). We conclude that a ∼50% deficit in β-cell mass can recapitulate the alterations in glucose-mediated insulin secretion and insulin action in humans with IFG and IGT. These data support a mechanistic role of a deficit in β-cell mass in the evolution of IFG/IGT and subsequently type 2 diabetes.

[1]  Johannes D Veldhuis,et al.  Pulsatile insulin secretion dictates systemic insulin delivery by regulating hepatic insulin extraction in humans. , 2005, Diabetes.

[2]  Johannes D. Veldhuis,et al.  Induction of β-cell rest by a Kir6.2/SUR1-selective KATP-Channel opener preserves β-cell insulin stores and insulin secretion in human islets cultured at high (11 mM) glucose , 2004 .

[3]  J. Leahy,et al.  Beta-cell hypersensitivity for glucose precedes loss of glucose-induced insulin secretion in 90% pancreatectomized rats , 1993, Diabetologia.

[4]  R. DeFronzo,et al.  Hepatic and peripheral insulin resistance: A common feature of Type 2 (non-insulin-dependent) and Type 1 (insulin-dependent) diabetes mellitus , 1982, Diabetologia.

[5]  P. Butler,et al.  Induction of beta-cell rest by a Kir6.2/SUR1-selective K(ATP)-channel opener preserves beta-cell insulin stores and insulin secretion in human islets cultured at high (11 mM) glucose. , 2004, The Journal of clinical endocrinology and metabolism.

[6]  Insulin secretion: a high-affinity Ca2+ sensor after all? , 2004, The Journal of general physiology.

[7]  P. Butler,et al.  Diazoxide attenuates glucose-induced defects in first-phase insulin release and pulsatile insulin secretion in human islets. , 2003, Endocrinology.

[8]  Robert A. Rizza,et al.  β-Cell Deficit and Increased β-Cell Apoptosis in Humans With Type 2 Diabetes , 2003, Diabetes.

[9]  T. W. Haeften,et al.  Disturbances in β-Cell Function in Impaired Fasting Glycemia , 2002 .

[10]  M. Straume,et al.  Decrease in beta-cell mass leads to impaired pulsatile insulin secretion, reduced postprandial hepatic insulin clearance, and relative hyperglucagonemia in the minipig. , 2001, Diabetes.

[11]  P. Butler,et al.  Anesthesia rapidly suppresses insulin pulse mass but enhances the orderliness of insulin secretory process. , 2001, American journal of physiology. Endocrinology and metabolism.

[12]  N. Porksen,et al.  Overnight inhibition of insulin secretion restores pulsatility and proinsulin/insulin ratio in type 2 diabetes. , 2000, American journal of physiology. Endocrinology and metabolism.

[13]  C. Bogardus,et al.  Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance. , 1999, Diabetes.

[14]  C. Bogardus,et al.  The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus. , 1999, The Journal of clinical investigation.

[15]  J. Gerich Metabolic abnormalities in impaired glucose tolerance. , 1997, Metabolism: clinical and experimental.

[16]  Y. Ueki,et al.  Glucose Tolerance, Insulin Secretion, and Insulin Sensitivity in Nonobese and Obese Japanese Subjects , 1997, Diabetes Care.

[17]  N. Porksen,et al.  Effects of somatostatin on pulsatile insulin secretion: elective inhibition of insulin burst mass. , 1996, The American journal of physiology.

[18]  N. Porksen,et al.  Pulsatile insulin secretion accounts for 70% of total insulin secretion during fasting. , 1995, The American journal of physiology.

[19]  C. Cobelli,et al.  Methods for assessment of the rate of onset and offset of insulin action during nonsteady state in humans. , 1993, The American journal of physiology.

[20]  E. Seaquist,et al.  Effects of hemipancreatectomy on pancreatic alpha and beta cell function in healthy human donors. , 1992, The Journal of clinical investigation.

[21]  H. Yki-Jărvinen,et al.  Mechanisms of Hyperglycemia-Induced Insulin Resistance in Whole Body and Skeletal Muscle of Type I Diabetic Patients , 1992, Diabetes.

[22]  D. Kelley,et al.  Role of reduced suppression of glucose production and diminished early insulin release in impaired glucose tolerance. , 1992, The New England journal of medicine.

[23]  E. Samols,et al.  Deterioration of Islet β-Cell Function After Hemipancreatectomy in Dogs , 1991, Diabetes.

[24]  R. Rizza,et al.  Contribution to Postprandial Hyperglycemia and Effect on Initial Splanchnic Glucose Clearance of Hepatic Glucose Cycling in Glucose-Intolerant or NIDDM Patients , 1991, Diabetes.

[25]  G. Ward,et al.  Effects of Prolonged Pulsatile Hyperinsulinemia in Humans: Enhancement of Insulin Sensitivity , 1990, Diabetes.

[26]  J. Najarian,et al.  Effects of hemipancreatectomy on insulin secretion and glucose tolerance in healthy humans. , 1990, The New England journal of medicine.

[27]  R. Rizza,et al.  Hepatic and Extrahepatic Responses to Insulin in NIDDM and Nondiabetic Humans: Assessment in Absence of Artifact Introduced by Tritiated Nonglucose Contaminants , 1990, Diabetes.

[28]  C. J. Goodner,et al.  Decreased Insulin- and Glucagon-Pulse Amplitude Accompanying β-Cell Deficiency Induced by Streptozocin in Baboons , 1989, Diabetes.

[29]  M. Monden,et al.  Insulin and Glucagon Secretion After Pancreatectomies Correlation of Secretion and Hormonal Contents of Remaining Pancreas , 1989, Diabetes.

[30]  J. Leahy,et al.  Compensatory adaption to partial pancreatectomy in the rat. , 1989, Endocrinology.

[31]  G. Paolisso,et al.  Advantageous metabolic effects of pulsatile insulin delivery in noninsulin-dependent diabetic patients. , 1988, The Journal of clinical endocrinology and metabolism.

[32]  D. Porte,et al.  Reduction of Glycemic Potentiation: Sensitive Indicator of β-Cell Loss in Partially Pancreatectomized Dogs , 1988, Diabetes.

[33]  H. Yki-Järvinen,et al.  Hyperglycemia Decreases Glucose Uptake in Type I Diabetes , 1987, Diabetes.

[34]  H. Orskov,et al.  Glucose uptake and pulsatile insulin infusion: euglycaemic clamp and [3-3H]glucose studies in healthy subjects. , 1986, Acta endocrinologica.

[35]  J. Leahy,et al.  Experimental reduction of B-cell mass: implications for the pathogenesis of diabetes. , 1986, Diabetes/metabolism reviews.

[36]  J. Leahy,et al.  Abnormal Insulin Secretion in a Streptozocin Model of Diabetes: Effects of Insulin Treatment , 1985, Diabetes.

[37]  M. Löhr,et al.  Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited. , 1985, Survey and synthesis of pathology research.

[38]  F. Marincola,et al.  Accommodation to a reduced islet cell mass in dogs. , 1984, The American journal of physiology.

[39]  R. Turner,et al.  Pulsatile Insulin Has Greater Hypoglycemic Effect Than Continuous Delivery , 1983, Diabetes.

[40]  E. Bonora,et al.  Decreased hepatic insulin extraction in subjects with mild glucose intolerance. , 1983, Metabolism: clinical and experimental.

[41]  K. Kosaka,et al.  Isoproterenol-stimulated C-peptide and insulin secretion in diabetic and nonobese normal subjects: decreased hepatic extraction of endogenous insulin in diabetes. , 1980, The Journal of clinical endocrinology and metabolism.